1313 papers
Neuroscience explores the intricate machinery of the brain and nervous system, seeking to understand how we think, feel, and move. From the microscopic dance of individual neurons to the complex networks that shape our memories and behaviors, this field peels back the layers of our biological selves to reveal the origins of consciousness and disease.
At Gist.Science, we bring these discoveries directly from bioRxiv, the leading preprint server for biological sciences, to a broader audience. We process every new neuroscience preprint as it is uploaded, transforming dense academic manuscripts into clear, plain-language explanations alongside detailed technical summaries. This ensures that both curious readers and specialists can stay current with the latest breakthroughs before they are formally published.
Below are the latest neuroscience papers we have processed from bioRxiv, offering fresh insights into the workings of the mind.
This paper introduces a large-scale behavioral benchmark for human environmental sound recognition and demonstrates that artificial neural networks trained on real-world multi-source scenes achieve near-human accuracy and alignment with brain responses, outperforming traditional auditory models.
By combining kinematic analysis, muscle recordings, and optogenetic perturbations in mice, this study identifies a specific population of spinal dILB6 excitatory interneurons as the cellular substrate that autonomously generates the coordinated multi-joint hindlimb flexion required for the flight phase of natural jumping, thereby providing concrete evidence for the concept of modular spinal motor control.
This study demonstrates that neuromodulators like dopamine and acetylcholine dynamically reconfigure cortical circuit computation by cell-type and receptor-specifically reshaping both individual neuronal properties and the functional architecture linking them, thereby expanding the computational repertoire beyond simple gain control.
This paper introduces Zapit, a complete open-source platform that enables spatio-temporally precise, random-access laser-scanning optogenetic experiments in head-fixed mice, offering a flexible and non-invasive alternative to traditional fiber-based methods for studying causal neural mechanisms.
This study demonstrates that GLP-1R agonists directly activate human hypothalamic neurons derived from pluripotent stem cells by inducing membrane depolarization and increased firing via PKA and L-type calcium channels, thereby providing a mechanistic explanation for how these drugs suppress appetite in humans.
This study presents the first single-cell transcriptional map of the chick intermediate medial mesopallium (IMM), revealing over 30 distinct cell clusters and identifying specific lncRNAs and protein-coding genes that correlate with visual imprinting memory strength.
Inspired by biological mechanisms, this paper proposes a modular Echo State Network that utilizes noradrenaline and acetylcholine gain modulation to dynamically reconfigure functional connectivity between integration and segregation, thereby enhancing performance on context-dependent tasks without altering structural connectivity.
This randomized controlled trial demonstrates that suppressive transcranial focused ultrasound targeting the posterior cingulate cortex can accelerate neuroplastic changes in novice meditators by increasing segregation between the default mode and central executive networks, thereby enhancing equanimity and meditation adherence.
This study demonstrates that stress-enhanced fear learning (SEFL) potentiates fear memory by specifically increasing the reactivation of fear engram cells in the ventral (caudal) dentate gyrus, while leaving cell numbers and reactivation in the dorsal (rostral) dentate gyrus unaffected.
This study pioneers the development of GPR52-1.0, a genetically encoded fluorescent sensor that enables real-time monitoring of GPR52 activation and neuronal ligand release, thereby providing a critical tool for deorphanizing this receptor and advancing the discovery of GPR52-targeted therapeutics.